(S)-(1,4-DIMETHYLPIPERAZIN-2-YL)METHANOL, 95.0%, 5g

Boc-3,5-Dibromo-L-tyrosine, 95.0%, 25g

Ethyl acetate, min. 99.5%, for synthesis, 5 l, plastic packaging.

(R)-3-(3-Fluoro-phenyl)-5-hydroxymethyl-oxazolidin-2-one, 95.0%, 5g

Tert-butyl 12-bromododecanoate, 97%, 100mg

(6-oxopyridazin-1(6{H})-yl)acetic acid, 95.0%, 5g

(3S,5S)-1-Benzyl-3,5-dimethylpiperazine hydrochloride, 97%, 100mg

9-Decenoic Acid>98.0%(T)5mL

4-Hydroxypyridine-3-sulfonic Acid>98.0%(HPLC)(T)25g

(R)-4-(Pyrrolidin-2-yl)benzonitrile hydrochloride, 97%, 1g

2,4-Diaminopyrimidine>98.0%(GC)(T)25g

2,6-Dichlorobenzothiazole>98.0%(GC)1g

Ethyl 2-Chloro-2-(hydroxyimino)acetate>99.0%(T)5g